| Ytd | -69.47% | |
| 1y | -96.00% |
| Open | 0.51 | Prev Close | 0.52 | Low | 0.50 | High | 0.55 | Mkt Cap | 5.84M |
| Vol | 113.32K | Avg Vol | 649.84K | EPS | -5.06 | P/E | N/A | Forward P/E | -0.43 |
| Beta | -1.29 | Short Ratio | 0.02 | Inst. Own | 10.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.75 | 200-d Avg | 3.63 | 1yr Est | 7.50 |
Patent Covers Acclaim-3 Clinical Trials Combining REQORSA Gene Therapy with Genentech, Inc.'s Te
https://www.sec.gov/Archives/edgar/data/1595248/000143774926019760/gnpx20260518_s3.htm